The promise nobody remembered.

Eighteen months ago, response to a 483 observation: "We will implement a revised cleaning validation protocol by Q2 2024." Inspector accepted. Warning letter avoided. Everyone moved on.

Now it's Q3 2024. New inspector. Different district office. "You committed to implementing a revised cleaning validation protocol. Show me the protocol."

The VP who wrote the commitment retired. The QA director left for a competitor. The current team wasn't there eighteen months ago. They're searching the former VP's email archive. The inspector waits. The commitment wasn't tracked anywhere except the 483 response letter. A PDF sitting in a folder nobody has opened since it was filed.

When you promise a health authority you'll do something by a specific date, that promise doesn't expire when the people who made it leave the organization. The FDA remembers. They have systems specifically designed to track your commitments across inspections, across years, across inspector rotations.

Your quality system almost certainly doesn't. Commitments from 483 responses live in PDF letters. Post-approval study commitments live in submission correspondence. Labeling update deadlines live in approval letters. Each one has a specific deliverable, a specific date, and a regulator who will eventually ask for evidence of completion.

Most organizations track these in spreadsheets or task lists that depend on the person who created them. When that person leaves, the institutional memory walks out with them. The commitment doesn't surface again until an inspector asks about it. And by then, you've missed the deadline.

Seal treats every regulatory commitment as a tracked obligation with a deadline countdown, defined evidence requirements, and automatic escalation. Sixty days before a commitment comes due, the responsible team gets notified. Thirty days out, management gets notified. If the deadline passes without completion evidence, the system escalates to the head of quality.

When that new inspector asks "show me your commitment status," the answer is a list with completion dates and attached evidence. Not a scramble through archived emails.

Your product sells in 47 markets. Each registration has a renewal date. Thailand renews annually. Brazil every five years. EU CE certificates on varying schedules. Japan re-registration every five years with data requirements that differ from the original approval.

The regulatory affairs coordinator maintains this in a spreadsheet. Updated monthly. Reminders set in their personal calendar. It works. Until they go on maternity leave. The backup doesn't have the same calendar reminders. Thailand renewal is due in six weeks. Nobody sees it.

The registration lapses. Your Thai distributor can't sell for four months while you file for reinstatement. Revenue lost. Relationship damaged. When investor due diligence asks "have you ever lost market authorization due to administrative failure," the answer is now yes.

This failure mode is entirely preventable. It happens because renewal tracking depends on a person instead of a system. Seal maintains a global registration database where every product-market combination has a status, an expiry date, and an escalation chain that operates independently of any individual. The system doesn't go on leave.

You modified a manufacturing process. Adjusted a mixing parameter to improve yield. In the US, this qualifies as an annual reportable change. You implement the change, ship product, and include it in next year's annual report. Perfectly compliant.

Six months later, commercial wants to ship the same product to Germany. Your regulatory team reviews and discovers: in the EU, this same change requires a Type II variation with pre-approval. You cannot ship to Germany until the variation is approved. The approval timeline is 60 days at best. The commercial opportunity is now.

This happens because different markets classify the same change differently. A process parameter adjustment that's reportable in the US may require prior approval in the EU, a Category I notification in Japan, and a variation in Brazil. If your change control system doesn't show the global regulatory impact of a proposed change, you'll discover the problem after you've already implemented it in one market and need to ship to another.

Seal maps changes to regulatory impact by market. When a change is proposed in the change control system, the regulatory module shows which markets require submissions, which require pre-approval, and which allow immediate implementation. The decision to proceed isn't made blind. It's made with full visibility into the downstream regulatory consequences.

"Can we sell Product X in Brazil?" "Is our EU registration still current?" "When does the Japan re-registration expire?" "Are there any markets where we've lost authorization?"

These questions shouldn't require a phone call to regulatory affairs. They should be answered by a database that's always current. Because it's updated by the same system that tracks submissions, renewals, and variations. Seal gives commercial teams read access to registration status without exposing submission strategy or proprietary regulatory content. They see what's approved, where, and until when. Regulatory sees everything else.

The registration database isn't a reference document someone maintains. It's a live view of your global regulatory position, computed from the submissions, approvals, and renewals recorded in the system.